Article info
Brief communication
Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: an interventional open-label study
- Correspondence to Professor Liam G Heaney, Centre for Experimental Medicine, Queens University Belfast, Belfast BT9 7BL, UK; l.heaney{at}qub.ac.uk
Citation
Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: an interventional open-label study
Publication history
- Received October 10, 2018
- Revised January 7, 2019
- Accepted February 25, 2019
- First published April 2, 2019.
Online issue publication
February 07, 2024
Article Versions
- Previous version (7 February 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.